Antipsychotic articles & resources on Made-in-China.com

Omeros Corporation Announced Positive Results From a Phase 2A Clinical Trial of OMS824

Feb 7, 2014

Omeros Corporation (NASDAQ: OMER) today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic ...

Tags: NASDAQ, PDE, PET, OM824

There Is Much Value in Training Hospital and Nursing Home Staff

Jan 22, 2014

There is much value in training hospital and nursing home staff in the basics of palliative care to make the last days of a dying patient's life as comfortable and dignified as possible. So says F. Amos Bailey of the Birmingham Veterans ...

Tags: Health, Medicine

Levels of Glutamine Are Elevated in The Dorsal Anterior Cingulate of Patients

Jan 15, 2014

By Eleanor McDermid, Senior medwireNews Reporter Levels of glutamine, but not glutamate, are elevated in the dorsal anterior cingulate of patients with established schizophrenia, say researchers. Most previous studies have measured ...

Tags: Health, Medicine

Study Reduces Aggressive and Serious Behavioral Problems in The Children

Dec 22, 2013

Prescribing both a stimulant and an antipsychotic drug to children with physical aggression and attention-deficit/hyperactivity disorder (ADHD), along with teaching parents to use behavior management techniques, reduces aggressive and ...

Tags: Health, Medicine

BBRF Has Announced The Latest Recipients of Its Narsad Distinguished Investigator Grants

Nov 12, 2013

The Brain & Behavior Research Foundation (BBRF) (formerly known as NARSAD, the National Alliance for Research on Schizophrenia and Depression), under the direction of president and CEO Dr Jeffrey Borenstein, has announced the latest ...

Tags: Narsad, BBRF, investigator, award

Grupo Ferrer Internacional Has Begun Sales of Adasuve Inhalation Powder

Aug 2, 2013

Grupo Ferrer Internacional, Alexza Pharmaceuticals' commercial partner, has begun sales of Adasuve inhalation powder, pre-dispensed (Staccato Loxapine) in the European Union (EU). The first sale triggered a $1.25m milestone payment to ...

Tags: Inhalation Powder, Grupo

LGC Standards LoGiCal Reference Solutions Are Proving Beneficial

Jan 5, 2013

LGC Standards’ LoGiCal reference solutions are proving beneficial to the Eastern Finland Laboratory Centre Joint Authority Enterprise (ISLAB) laboratory at Kuopio University Hospital. ISLAB performs around eight million analyses ...

Tags: LGC Standards, healthcare

Janssen Pharmaceuticals Settled Legal Cases with 36 States

Dec 6, 2012

Janssen Pharmaceuticals has settled its legal cases with 36 states and the District of Columbia regarding promotional and marketing practices for its atypical antipsychotic prescription medication Risperdal. The company will shell out ...

Tags: atypical antipsychotic prescription medication, rispedal

SureGene,PGXL to launch the SureGene Test for Antipsychotic and Antidepressant Response

Dec 4, 2012

SureGene and PGXL Laboratories have joined forces to launch the SureGene Test for Antipsychotic and Antidepressant Response (STA2R), which is a pharmacogenetic test containing genetic markers for effectiveness of antipsychotic drug ...

Tags: STA2R, SureGene Test, pharmacogenetic test

Zogenix Has Commenced First Ind Clinical Trial for Relday

Nov 29, 2012

Zogenix has commenced first IND clinical trial for Relday in patients with chronic, stable schizophrenia or schizoaffective disorder. Relday is based on a combination of its DosePro needle-free, subcutaneous drug delivery system with a ...

Tags: Clinical Trial, DosePro needle-free drug, pharmacokinetic

Catalent Has Started Supplying Its Antipsychotic Drug

Nov 28, 2012

Catalent has started supplying its antipsychotic drug, Abilify, an orally disintegrating tablet (ODT) to Otsuka Pharmaceutical. Abilify ODT, which utilizes Catalent's Zydis fast dissolve drug delivery technology, is designed to improve ...

Tags: Catalent, Abilify Antipsychotic Drug, Otsuka Pharma, antipsychotic drug

Mitsubishi Tanabe Shows News Dosage to Antipsychotic Agent

Nov 27, 2012

Mitsubishi Tanabe Pharma is introducing Depas tablets 0.25mg, a new dosage to be added to the series of tranquilizer being currently available under the brand names Depas tablets 0.5mg, Depas tablets 1gm and Depas fine granules 1%, in ...

Tags: Mitsubishi, Depas tablets, Antipsychotic

Antipsychotic

Related Products